Key result
Long-term low-dose acetylsalicylic acid therapy effectively prevents cardiovascular events but increases the risk of digestive adverse reactions, necessitating specific preventive strategies.
This review summarizes strategies to mitigate the risk of gastrointestinal adverse reactions associated with long-term low-dose acetylsalicylic acid therapy.
Acetylsalicylic acid (ASA) is highly effective in preventing cardiovascular events, but associated with increased risk for digestive adverse reactions. The paper provides an update on the epidemiology, mechanisms, and risk factors of esophagogastroduodeno- and enteropathies during long-term low-dose ACA therapy. It outlines the key principles of their prevention.
No takes yet. Share an insight, caveat, or question.
Е. В. Онучина (2014) studied this question. Long-term low-dose acetylsalicylic acid therapy effectively prevents cardiovascular events but increases the risk of digestive adverse reactions, necessitating specific preventive strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: